| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/23/1998 | EP0865290A1 Pharmaceutical compositions for oral use including an nsaid and ceramides |
| 09/23/1998 | EP0711280B1 Perhydroisoindole derivatives as p substance antagonists |
| 09/23/1998 | EP0680321B1 Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide |
| 09/23/1998 | EP0618916B1 Anti-rheumatic naphthyridine derivatives |
| 09/23/1998 | CN1193980A G-protein receptor HTNAD 29 |
| 09/23/1998 | CN1193979A Macrolides |
| 09/23/1998 | CN1193978A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 09/23/1998 | CN1193974A £1,2,4| triazolo £4,3-1| quinoxalinone derivatives, their preparation and use |
| 09/23/1998 | CN1193973A £1,2,4| triazolo £4,3-a| quinoxalinone derivatives, their preparation and use |
| 09/23/1998 | CN1193966A Aromatic compounds and pharmaceutical compositions containing them |
| 09/23/1998 | CN1193961A Substituted benzylaminopiperidine compounds |
| 09/23/1998 | CN1193911A Use of basic amino acids and derivatives for lowering ceramide levels |
| 09/23/1998 | CN1193623A Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them |
| 09/22/1998 | US5811582 Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients |
| 09/22/1998 | US5811562 Pharmceutical compositions for the treatment of osteoporosis, wound healing, transplant rejection, rheumatoid arthritis |
| 09/22/1998 | US5811558 Process for the resolution of etodolac using glucamine derivatives |
| 09/22/1998 | US5811553 Quinoline derivatives(2) |
| 09/22/1998 | US5811549 Process of preparing imidazole compounds |
| 09/22/1998 | US5811535 Human cartilege gp39-like gene |
| 09/22/1998 | US5811459 Pain relievers |
| 09/22/1998 | US5811455 Compounds useful for treating allergic or inflammatory diseases |
| 09/22/1998 | US5811451 Antiinflammatory agents; infections; osteoporosis; autoimmune diseases; human and veterinary medicine; cattle, dogs, horses; gastrointestinal and respiratory dsystem disorders; glandular disorders |
| 09/22/1998 | US5811449 Administering a suppressor pyrrolidine dithiocarbamate to prevent the oxidation of a polyunsaturated fatty acid |
| 09/22/1998 | US5811438 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products |
| 09/22/1998 | US5811431 Treating or preventing pain, inflammation, migraine, emesis, postherpetic neuralgia |
| 09/22/1998 | US5811410 Nonsteroidal antiinflammatory drugs |
| 09/22/1998 | US5811405 Pharmaceuticals, diagnostic agents |
| 09/22/1998 | US5811392 Conformationally constrained backbone cyclized peptide analogs |
| 09/22/1998 | US5811388 Delivery of drugs to the lower GI tract |
| 09/22/1998 | US5811126 Mixtures of alginates, water-swellable macromolecules, edible hydrocarbon derivatives, divalent metal salts to crosslink the alginates and therapeutically active materials |
| 09/22/1998 | CA2135603C Solid dispersion compositions of tebufelone |
| 09/22/1998 | CA2093797C Substituted imidazobenzazepines and imidazopyridoazepines |
| 09/22/1998 | CA2086434C Quinuclidine derivatives |
| 09/17/1998 | WO1998040488A1 Anti-alphabeta3 humanized monoclonal antibodies |
| 09/17/1998 | WO1998040404A2 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | WO1998040381A1 Inhibitors of impdh enzyme |
| 09/17/1998 | WO1998040370A1 Lta4 hydrolase inhibitors |
| 09/17/1998 | WO1998040364A1 Lta4 hydrolase inhibitors |
| 09/17/1998 | WO1998040079A1 Serine proteinase inhibitory activity by hydrophobic tetracycline |
| 09/17/1998 | WO1998040070A1 Compositions containing capsaicin or capsaicin analogues and a local anesthetic |
| 09/17/1998 | WO1998040049A2 Specific magnetosome, method for the production and use thereof |
| 09/17/1998 | WO1998039970A1 Quinoline leukotriene antagonists |
| 09/17/1998 | WO1998031343A3 Aqueous suspension for nasal administration of loteprednol |
| 09/17/1998 | WO1998024905A3 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | DE19805370A1 New aromatic amino compounds |
| 09/17/1998 | DE19711053A1 Kombinationspräparat aus 2-Methyl-thiazolidin-2,4-dicarbonsäure und Paracetamol Combination preparation of 2-methyl-thiazolidine-2,4-dicarboxylic acid and acetaminophen |
| 09/17/1998 | DE19708713A1 Verwendung von anti-CD44 Antikörpern enthaltenden Präparationen zur Behandlung bestimmter Tumore und zur Unterdrückung von Immunreaktionen Using anti-CD44 antibodies containing preparations for the treatment of certain tumors and for the suppression of immune responses |
| 09/17/1998 | DE19706490C1 Verfahren zur Herstellung von Säureamiden und zur Metallierung von Verbindungen und Verwendung der nach den Verfahren hergestellten Verbindungen Process for the preparation of acid amides and the metalation of compounds and use of the compounds prepared by the processes |
| 09/17/1998 | CA2284518A1 Anti-alphabeta3 humanized monoclonal antibodies |
| 09/17/1998 | CA2283227A1 Medicinal preparation containing a lipophilic inert gas |
| 09/17/1998 | CA2283193A1 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | CA2282710A1 Lta4 hydrolase inhibitors |
| 09/17/1998 | CA2282398A1 Inhibitors of impdh enzyme |
| 09/17/1998 | CA2282349A1 Lta4 hydrolase inhibitors |
| 09/16/1998 | EP0864559A1 Substituted amino compounds and their use as analgesic active substances |
| 09/16/1998 | EP0864323A1 Pharmaceutical preparation for oral application containing a histamine-immunoglobulin complex |
| 09/16/1998 | EP0863915A1 ACYLATED ENOL DERIVATIVES OF $g(a)-KETOESTERS AND $g(a)-KETOAMIDES |
| 09/16/1998 | EP0863905A1 Novel imidazole lipoxygenase inhibitors |
| 09/16/1998 | EP0863891A1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors |
| 09/16/1998 | EP0863885A2 Novel macrocyclic compounds as metalloprotease inhibitors |
| 09/16/1998 | EP0863883A1 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 09/16/1998 | EP0863881A1 Benzimidazole derivatives and their use in the prevention and/or the treatment of bone diseases |
| 09/16/1998 | EP0863876A1 Quinoline derivatives containing a diol as leukotriene antagonists |
| 09/16/1998 | EP0863873A1 Indole carbamates as leukotriene antagonists |
| 09/16/1998 | EP0863870A1 Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents |
| 09/16/1998 | EP0863765A1 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 09/16/1998 | EP0863757A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 09/16/1998 | EP0863754A1 Hydrolysis-optimized lipid emulsions and use thereof |
| 09/16/1998 | EP0733047B1 Substituted oxazolidines with stimulating effect of beta-adrenergig receptor |
| 09/16/1998 | EP0728128B1 Substituted phenyl compounds |
| 09/16/1998 | EP0650496B1 Anti-inflammatory compounds for ophthalmic use |
| 09/16/1998 | EP0649432B1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 09/16/1998 | CN1193325A Cell adhension inhibitors |
| 09/16/1998 | CN1193313A Propynyl or dienyl diaromatic compounds |
| 09/16/1998 | CN1193275A Percutaneous tap preparation containing fentanyl |
| 09/16/1998 | CN1193022A Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist |
| 09/16/1998 | CN1192929A Oral medicinal preparation |
| 09/16/1998 | CN1192928A Production process for medicinal liquor |
| 09/15/1998 | US5808097 Proline derivatives |
| 09/15/1998 | US5808029 Genetic engineering |
| 09/15/1998 | US5808018 Fluorine containing sialyl Lewis X derivatives and synthetic intermediates thereof |
| 09/15/1998 | US5807951 Pharmaceutical composition regulating function of a living body |
| 09/15/1998 | US5807886 Treatment of neurodegenerative disorders, migraine, drug addiction |
| 09/15/1998 | US5807885 Amidine derivatives with nitric oxide synthetase activities |
| 09/15/1998 | US5807884 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 09/15/1998 | US5807881 Method for selectively reducing activated leukocyte cell population |
| 09/15/1998 | US5807876 Inosine-5'-monophospate dehydrogenase; viral diseases, cancer, vascular diseases; merimepodib |
| 09/15/1998 | US5807867 Quinuclidine derivatives |
| 09/15/1998 | US5807862 Therapeutic compounds containing pyrimidinyl moieties |
| 09/15/1998 | US5807859 Antiischemic agents; brain disorders |
| 09/15/1998 | US5807824 C5A receptor antagonists having substantially no agonist activity |
| 09/15/1998 | US5807820 Cyclosporin compositions for topical application |
| 09/15/1998 | US5807818 Therapeutic uses of bactericidal/permeability increasing protein (BPI) protein products |
| 09/15/1998 | US5807731 Antitumor |
| 09/15/1998 | CA2001750C Pyrrolidine derivatives |
| 09/14/1998 | CA2221830A1 Tumor necrosis factor related receptor, tr6 |
| 09/11/1998 | WO1998039444A1 Protein kinase c inhibitor-like protein (ipkc-2) |
| 09/11/1998 | WO1998039441A1 Human chemokine receptor-like chemokine |
| 09/11/1998 | WO1998039433A1 Complement receptor type 1 (cr1)-like sequences |
| 09/11/1998 | WO1998039426A2 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |